Brief: Poseida Therapeutics Provides Update on BCMA-Targeted CAR-T Clinical Trials at the 2021 American Society of Hematology (ASH) Annual Meeting

Poseida Therapeutics

13/12/2021 13:15

Dec 13 (Reuters) - Poseida Therapeutics Inc  PSTX.O :
    * POSEIDA THERAPEUTICS PROVIDES UPDATE ON BCMA-TARGETED
CAR-T
CLINICAL TRIALS AT THE 2021 AMERICAN SOCIETY OF HEMATOLOGY (ASH)
ANNUAL MEETING

Source text for Eikon:  ID:nPn7q4Vfxa 
Further company coverage:  PSTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))